369 related articles for article (PubMed ID: 2474352)
1. The ability of denbufylline to inhibit cyclic nucleotide phosphodiesterase and its affinity for adenosine receptors and the adenosine re-uptake site.
Nicholson CD; Jackman SA; Wilke R
Br J Pharmacol; 1989 Jul; 97(3):889-97. PubMed ID: 2474352
[TBL] [Abstract][Full Text] [Related]
2. Tissue selective inhibition of cyclic nucleotide phosphodiesterase by denbufylline.
Wilke R; Arch JR; Nicholson CD
Arzneimittelforschung; 1989 Jun; 39(6):665-7. PubMed ID: 2476135
[TBL] [Abstract][Full Text] [Related]
3. Endothelium-dependent and independent relaxation of the rat aorta by cyclic nucleotide phosphodiesterase inhibitors.
Komas N; Lugnier C; Stoclet JC
Br J Pharmacol; 1991 Oct; 104(2):495-503. PubMed ID: 1665741
[TBL] [Abstract][Full Text] [Related]
4. Incomplete reversal of beta-adrenoceptor desensitization in human and guinea-pig cardiomyocytes by cyclic nucleotide phosphodiesterase inhibitors.
Wynne DG; Poole-Wilson PA; Harding SE
Br J Pharmacol; 1993 Aug; 109(4):1071-8. PubMed ID: 7691363
[TBL] [Abstract][Full Text] [Related]
5. On the adenosine receptor and adenosine inactivation at the rat diaphragm neuromuscular junction.
Sebastião AM; Ribeiro JA
Br J Pharmacol; 1988 May; 94(1):109-20. PubMed ID: 2456805
[TBL] [Abstract][Full Text] [Related]
6. Effects of SK&F 94120, an inhibitor of cyclic nucleotide phosphodiesterase type III, on human platelets.
Simpson AW; Reeves ML; Rink TJ
Biochem Pharmacol; 1988 Jun; 37(12):2315-20. PubMed ID: 2455518
[TBL] [Abstract][Full Text] [Related]
7. Inhibition by xanthine derivatives of adenosine receptor-stimulated cyclic adenosine 3',5'-monophosphate accumulation in rat and guinea-pig thymocytes.
Fredholm BB; Sandberg G
Br J Pharmacol; 1983 Dec; 80(4):639-44. PubMed ID: 6100843
[TBL] [Abstract][Full Text] [Related]
8. The low KM-phosphodiesterase inhibitor denbufylline enhances neuronal excitability in guinea pig hippocampus in vitro.
Sutor B; Alzheimer C; Ameri A; ten Bruggencate G
Naunyn Schmiedebergs Arch Pharmacol; 1990 Sep; 342(3):349-56. PubMed ID: 1704105
[TBL] [Abstract][Full Text] [Related]
9. The effect of alkylxanthines and other phosphodiesterase inhibitors on adenosine-receptor mediated decrease in lipolysis and cyclic AMP accumulation in rat fat cells.
Fredholm BB; Lindgren E
Acta Pharmacol Toxicol (Copenh); 1984 Jan; 54(1):64-71. PubMed ID: 6322517
[TBL] [Abstract][Full Text] [Related]
10. Evidence for adenosine A1 receptor action in rat jejunal mucosa.
Reymann A; Gniess A
Eur J Pharmacol; 1988 Apr; 149(1-2):155-8. PubMed ID: 2840297
[TBL] [Abstract][Full Text] [Related]
11. Stimulation of the hypothalamo-pituitary-adrenal axis in the rat by three selective type-4 phosphodiesterase inhibitors: in vitro and in vivo studies.
Kumari M; Cover PO; Poyser RH; Buckingham JC
Br J Pharmacol; 1997 Jun; 121(3):459-68. PubMed ID: 9179387
[TBL] [Abstract][Full Text] [Related]
12. 2-Chloro-[3H]-adenosine binding in isolated rat kidney membranes.
Wu PH; Churchill PC
Arch Int Pharmacodyn Ther; 1985 Jan; 273(1):83-7. PubMed ID: 2408594
[TBL] [Abstract][Full Text] [Related]
13. Adenosine inhibits the positive inotropic effect of 3-isobutyl-1-methylxanthine in papillary muscles without effect on cyclic AMP or cyclic GMP.
Böhm M; Brückner R; Neumann J; Nose M; Schmitz W; Scholz H
Br J Pharmacol; 1988 Apr; 93(4):729-38. PubMed ID: 2455577
[TBL] [Abstract][Full Text] [Related]
14. Caffeine and theophylline analogues: correlation of behavioral effects with activity as adenosine receptor antagonists and as phosphodiesterase inhibitors.
Choi OH; Shamim MT; Padgett WL; Daly JW
Life Sci; 1988; 43(5):387-98. PubMed ID: 2456442
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of eosinophil cyclic nucleotide PDE activity and opsonised zymosan-stimulated respiratory burst by 'type IV'-selective PDE inhibitors.
Dent G; Giembycz MA; Rabe KF; Barnes PJ
Br J Pharmacol; 1991 Jun; 103(2):1339-46. PubMed ID: 1653070
[TBL] [Abstract][Full Text] [Related]
16. Evidence for the involvement of cyclic GMP in adenosine-induced, age-dependent vasodilatation.
Moritoki H; Matsugi T; Takase H; Ueda H; Tanioka A
Br J Pharmacol; 1990 Jul; 100(3):569-75. PubMed ID: 2167736
[TBL] [Abstract][Full Text] [Related]
17. Theophylline-like properties of xanthine analogs.
Levallois C; Bonnafous JC; Francoise MA; Sablayrolles C; Chapat JP; Mani JC
Biochem Pharmacol; 1984 Jul; 33(14):2253-7. PubMed ID: 6087821
[TBL] [Abstract][Full Text] [Related]
18. An investigation of the low intrinsic activity of adenosine and its analogs at low affinity (A2) adenosine receptors in rat cerebral cortex.
Bazil CW; Minneman KP
J Neurochem; 1986 Aug; 47(2):547-53. PubMed ID: 3016175
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of high affinity and low affinity adenosine binding sites in human cerebral cortex.
John D; Fox IH
Adv Exp Med Biol; 1986; 195 Pt B():57-69. PubMed ID: 2429512
[TBL] [Abstract][Full Text] [Related]
20. Effects of phosphodiesterase inhibitors on human lung mast cell and basophil function.
Weston MC; Anderson N; Peachell PT
Br J Pharmacol; 1997 May; 121(2):287-95. PubMed ID: 9154339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
